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Abstract
Background: Stimulation of epithelial sodium channel (ENaC) increases Na
+ transport, a driving force of alveolar
fluid clearance (AFC) to keep alveolar spaces free of edema fluid that is beneficial for acute lung injury (ALI). It is
well recognized that regulation of ENaC by insulin via PI3K pathway, but the mechanism of this signaling pathway
to regulate AFC and ENaC in ALI remains unclear. The aim of this study was to investigate the effect of insulin on
AFC in ALI and clarify the pathway in which insulin regulates the expression of ENaC in vitro and in vivo.
Methods: A model of ALI (LPS at a dose of 5.0 mg/kg) with non-hyperglycemia was established in Sprague-
Dawley rats receiving continuous exogenous insulin by micro-osmotic pumps and wortmannin. The lungs were
isolated for measurement of bronchoalveolar lavage fluid(BALF), total lung water content(TLW), and AFC after ALI
for 8 hours. Alveolar epithelial type II cells were pre-incubated with LY294002, Akt inhibitor and SGK1 inhibitor 30
minutes before insulin treatment for 2 hours. The expressions of a-,b-, and g-ENaC were detected by
immunocytochemistry, reverse transcriptase polymerase chain reaction (RT-PCR) and western blotting.
Results: In vivo, insulin decreased TLW, enchanced AFC, increased the expressions of a-,b-, and g-ENaC and the
level of phosphorylated Akt, attenuated lung injury and improved the survival rate in LPS-induced ALI, the effects
of which were blocked by wortmannin. Amiloride, a sodium channel inhibitor, significantly reduced insulin-induced
increase in AFC. In vitro, insulin increased the expressions of a-,b-, and g-ENaC as well as the level of
phosphorylated Akt but LY294002 and Akt inhibitor significantly prevented insulin-induced increase in the
expression of ENaC and the level of phosphorylated Akt respectively. Immunoprecipitation studies showed that
levels of Nedd4-2 binding to ENaC were decreased by insulin via PI3K/Akt pathway.
Conclusions: Our study demonstrated that insulin alleviated pulmonary edema and enhanced AFC by increasing
the expression of ENaC that dependent upon PI3K/Akt pathway by inhibition of Nedd4-2.
Keywords: Alveolar fluid clearance, Akt, Epithelial sodium channel, Insulin, Phosphatidylinositol 3-kinase, Acute lung
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Introduction
Actue lung injury(ALI), the early stage of acute respira-
tory distress syndrome (ARDS), is a devastating clinical
syndrome characterized by alveolar epithelial injury lead-
ing to non-cardiogenic pulmonary edema of flooding
protein-rich fluid in the alveolar spaces with a mortality
of approach 40% [1,2]. In vivo, alveolar fluid volume is
determined by alveolar fluid clearance (AFC), the balance
of transepithelial Na
+ transport [3]. AFC was impaired in
ALI and removal of excessive alveolar edema fluid is an
important way for effective treatment and better outcome
[4,5].
It has been generally believed that epithelial sodium
channel (ENaC) is the primary determinant of AFC, a
driving force to remove edema fluid from alveolar
spaces on the ion transport-dependent mechanism [6-8].
ENaC is composed of three homologous subunits, a, b
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sues including alveolar epithelial cells [9,10]. Unable to
clear alveolar edema fluid, a-ENaC gene knock-out
mice died within 40 hours after birth [11].b-ENaC gene
in alveolar epithelium was proved to be required for
AFC in mice [12]. The mice lacking g-ENaC gene influ-
enced the alveolar edema fluid absorption that was
essential for AFC [13]. Thus, the three subunits of
ENaC play a key role in AFC.
The phosphatidylinositol 3-kinase (PI3K) family,
divided into IA, IB, II, and III classes, consists of a cataly-
tic domain and a regulatory domain and participates cell
responses including cell survival, metabolism,gene
expression,vesicular trafficking, cytoskeletal rearrange-
ment and migration [14,15]. Insulin increases Na
+ trans-
port by trafficking ENaC subunits to the apical
membrane in kidney cells via PI3K-dependent mechan-
ism [16,17]. PI3K has been identified as integral for regu-
lation of ENaC by insulin [18]. It is well established that
insulin activates PI3K by linking to the insulin receptor
and generating phosphatidylinositol-3,4,5-triphosphate to
promote the activation of protein kinase B(Akt), an
important downstream kinase that regulates glycogen
and protein synthesis [19,20]. Upon insulin stimulation,
the pleckstrin homology domain of Akt binds to lipid
messengers and is phosphorylated at Thr308 and Ser473
by recruition to the plasma membrane [21]. However,
how this signaling pathway transduction converge to reg-
ulate AFC and three subunits of ENaC in ALI has not yet
been elucidated.
In this study, we aimed to investigate the effect of insulin
on AFC and the expression of ENaC via PI3K/Akt path-
way in vitro and in vivo. We found that insulin attenuated
lung injury in LPS-induced ALI, alleviated pulmonary
edema and enhanced AFC by increasing the expression of
ENaC that dependent upon PI3K/Akt pathway by inhibi-
tion of Nedd4-2.
Methods
Materials
Male Sprague-Dawley rats weighing 200-250 g (Depart-
ment of Laboratory Animal Center, Chongqing Medical
University) were housed under specific pathogen-free con-
ditions in a temperature- and humidity-controlled envir-
onment and given free access to food and water with the
G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l s .
Reagents for cell culture were provided by the Institute of
Life Science, Chongqing Medical University. Lipopolysac-
charide (LPS, Escherichia coli serotype O111:B4),
LY294002 (PI3K inhibitor [22]), wortmannin (PI3K inhibi-
tor [22]), amiloride (sodium channel inhibitor), sodium
pentobarbital and Evans blue were purchased from Sigma
(St Louis, MO, USA).
Akt inhibitor (1 L-6-hydroxymethyl-chiroinositol2
[(R)-2-Omethyl-3-O-octadecylcarbonate]) was purchased
from Enzo Life Sciences (Farmingdale, NY, USA).
Serum- and glucocorticoid-regulated protein kinase1
(SGK1) inhibitor (2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo
[2,3-b]pyridin-3-yl-benzoic acid) was purchased from
Tocris bioscience(Bristol, UK). Rabbit anti- a-ENaC,b-
ENaC and g-ENaC antibodies were purchased from
Santa Cruz Biotechnology(Santa Cruz, CA, USA) Rabbit
anti- Phospho-Akt (Ser473) and total Akt monoclonal
antibodies were obtained from Cell Signaling Technol-
ogy (Beverly, MA, USA). Rabbit anti-Nedd4-2 polyclonal
antibody was purchased from ABcam (Cambridge, MA,
USA).
The study was approved by the Ethics Committee of
the Second Affiliated Hospital of Chongqing Medical
University.
Animal model and intervention
Rats were anesthetized by intraperitoneal administration
of sodium pentobarbital (50 mg/kg). ALI model was
established by LPS (5.0 mg/kg) with intraperitoneal
injection followed by insertion of an internal jugular
vein catheter for drug administration. Human Insulin
(Humulin 70/30; Eli Lilly, Indianapolis, IN, USA) was
administered at a dose of 0.1 U/kg/h and at a rate of
2.5 mU/h/rat via micro-osmotic pumps(Zhejiang Uni-
versity Medical Instrument Co. Ltd., Hangzhou, China)
16 hours before LPS exposure. Wortmannin (0.06 mg/
kg) were injected retro-orbitally three times at -90, +90,
and +360 minutes relative to the LPS injection. Rats in
control group were received an equivalent volume of
saline. Rats were killed 8 hours after LPS or saline treat-
ment. Blood samples, bronchoalveolar lavage fluid
(BALF) and lung tissue were obtained for analysis.
Cell isolation, culture and treatment
Alveolar epithelial type II (ATII) cells were isolated
from male Sprague-Dawley rats by elastase digestion of
lung tissue and then differentially adhered on IgG-
coated plates as previously described [23]. Purity of the
ATII cells were determined by microscopic analysis,
indicative of epithelial cell lineage and by immunohis-
tochemistry for surfactant protein-C, indicative of ATII
cell. ATII cells were seeded onto plastic culture dishes
and cultured in a 5% CO2, 95% air atmosphere in
DMEM containing 10% fetal bovine serum, 100 U/ml
penicillin and 0.1 mg/ml streptomycin after isolation.
On day 3 after isolation, the cells were pre-incubated
with LY294002 (10 μM), Akt inhibitor(100 nM) and
SGK1 inhibitor(10 μM) for 30 minutes before insulin
(200 mU/L) treatment for 2 hours and the experiments
were performed.
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Blood samples were withdrawn from the catheter by cen-
trifuging at 3000 rpm at 4°C for 15 minutes. Glucose levels
in the plasma were analyzed by Glucometer OneTouch
(Johnson& Johnson Medical Ltd., Shanghai, China).
Human insulin levels in the plasma were analyzed by a
ELISA kit for only human insulin (10-1132-01; Mercodia,
Uppsala, Sweden). Total insulin levels in the plasma were
analyzed by a ELISA kit for rat plus human insulin (10-
1251-01; Mercodia).
Measurement of TNF-a, IL-6, protein levels and
myeloperoxidase assay in bronchoalveolar lavage fluid
BALF was performed on the right lung lavaged with 0.9%
NaCl (5 ml) at room temperature and was collected after
infusion with six times. More than 90% of BALF was col-
lected from each animal and was centrifuged at 14,000
rpm for 30 minutes at 4°C to remove cell debris. The
supernatant from the first two washes was pooled and
analyzed for total protein. The rest of BALF was stored at
-80°C for tumor necrosis factor-a(TNF-a), interleukin-6
(IL-6), and myeloperoxidase (MPO) analysis. The total
cell counts were determined by a hemocytometer and
differential cell counts were assessed on cytocentrifuge
preparations stained with Diff-Quik (Sigma, St. Louis,
MO, USA). The measurement of TNF-a, IL-6 were ana-
lyzed by Enzyme-linked immunosorbent assay (ELISA)
kits (R&D Systems, Minneapolis, MN, USA). Total pro-
tein levels were determined by a protein assay kit (Key-
GEN, KeyGEN Bio TECH Co., Nanjing, China). MPO
activity, an indicator of neutrophil activation [24], was
determined by a MPO assay kit (Nanjing Jiancheng
Bioengineering Institute, Nanjing, China). All assays were
done according to the manufacturer’s instructions.
Lung histology evaluation
The left lower lung lobes were harvested and fixed in 10%
neutral buffered formalin for 24 hours. Then they were
embedded in paraffin and stained with hematoxylin and
eosin (H&E) for microscope observation. A semi-quantita-
tive scoring system was adopted to evaluate the lung injury
including intraalveolar exudate, interstitial edema, alveolar
hemorrhage, and inflammatory cell infiltration [25]. The
grading scale of pathologic findings was used in a light
microscope:0 = no injury;1 = slight injury(25%);2 = moder-
ate injury(50%); 3 = severe injury(75%); and4 = very severe
injury (almost 100%).
Immunocytochemistry
The paraffin was dewaxinged with Xylene and hydrated
with ethanol, and then it was treated with 3%H2O2 to
inhibit endogenous peroxidase activity for 10 minutes
and rinsed with phosphate buffer solution (pH 7.6). It
was blocked with bovine serum albumin for 30 minutes
and incubated with primary antibodies at 4°C for
24 hours. Then, biotinylated anti-rabbit IgG (Santa Cruz
Biotechnology) was reacted for 30 minutes in an incuba-
tor at 37°C. After washing with phosphate buffer solution
for three times, it was reacted with avidin-biotin-peroxi-
dase complex (Sigma) for 30 minutes and then stained
with DAB (Sigma), a colouring agent, for 5 minutes. For
control staining, it was also reacted with hematoxylin for
30 seconds. Normal rabbit isotype IgG (Santa Cruz Bio-
technology) was a substitute for the primary antibodies
i nt h ea b o v ep r o c e s sa san e g a t i v ec o n t r o l .T h en u m b e r
of positive cells was counted in randomly 5 high-power
fields (magnification 400 ×) of each section and averaged
with a light microscopy.
Measurement of total lung water content and alveolar
fluid clearance
Total lung water content (TLW), a quantification of pul-
monary edema, was measured as previously described
[26]. The left lung was isolated for determination of
TLW. The lung was weighed in an automatic electric
balance (Sartorius, Goettingen, Germany), then placed
in an oven at 80°C for 48 hours and weighed again to
obtain its dry weight. TLW was calculated as follows:
TLW = (wet lung weigh-dry lung weight)/(dry lung
weight).
AFC was measured according to the established pro-
cedure [27]. Briefly, the isolated right lung was placed in
a humidified incubator at 37°C and ventilated with 100%
nitrogen to remove oxygen from the alveolar spaces.
Physiological saline solution (5 ml/kg) containing 5%
albumin and Evans blue dye (0.15 mg/ml) was injected
into the alveolar spaces at an airway pressure of 7 cm
H2O. Alveolar fluid was aspirated 1 h after instillation.
The concentrations of Evans blue-labeled albumin in
the injected and aspirated solutions were measured by a
spectrophotometer (Beckman Coulter, Los Angeles, CA,
USA). AFC was calculated as follows:
AFC = [(Vi -V f)/Vi] × 100% Vf =( V i − Pi)/Pf
V represents the injected volume (i) and final volume
(f) of alveolar fluid. P represents the injected (i) and
final (f) concentration of Evans blue-labeled 5% albumin
solution.
RNA extraction and Reverse Transcription Polymerase
Chain Reaction (RT-PCR) analysis
Total RNA was extracted from the lung tissue and cells
with a RNA extraction kit (TaKaRa, Japan), according to
the manufacture’s instructions. The concentration and
purity of RNA were estimated on a spectrophotometer.
Primer sequences for a-,b-, and g-ENaC were used for
PCR amplification: a-ENaC(509 bp), 5’- TACCCT
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GGAGACTCCGAATTAGT-3’(reverse);b-ENaC(406 bp),
5’-GCTAAAGAGCTAGCAG TAATGG-3’(forward)
and5’-CTGGTGTTTGTTATGCCTAGAG-3’(reverse);g-
ENaC(363 bp), 5’- GGATCCTGAGAGAGAATCATGC-
3’(forward)and5’-GTGTCCAGCTATGCCCTTTAAC-3’
(reverse);b-actin(871 bp), 5’-GTACAACCTTCTTG-
CAGCTCCT-3’(forward)and5’-ACAGGATT CCA-
TACCCAGGAAG -3’ (reverse). Two-step RT-PCR Kit
(TaKaRa, Japan) was used for reverse transcription with
PCR amplification analyzer(Eppendorf, Hamburg,
Germany). Reverse transcription reaction conditions
were 65°C for 5 minutes, 42°C for 30 minutes, 95°C for
5 minutes and4°C for 5 minutes. Polymerase chain reac-
tions comprised pre-denaturation at 94°C for 60 sec-
onds, 30 cycles of denaturation at 94°C for 30 seconds,
annealing at 53°C (a-ENaC), 53°C (b-ENaC), 55°C
(g-ENaC) and 55°C (b-actin) for 30 seconds and poly-
merization at 72°C for 60 seconds. Each PCR product
was run on a 1.0% agarose gel containing ethidium bro-
mide and was visualized with Gel Imaging System (Bio-
Rad, Hercules, CA, USA).
Western blotting analysis and immunoprecipitation
Proteins were obtained with 1 ml of lysis buffer and 1 ml
of extraction buffer by using a protein extraction kit(Key-
GEN) according to the manufacture’s instructions and
stored at -80°C for analysis. Proteins were separated by
10% SDS-PAGE and transferred to polyvinylidene fluoride
menbranes. After blocking with 5% nonfat dried milk in
Tris-buffered saline containing 0.05% Tween 20, the mem-
branes were incubated with primary antibodies a-, b-, g-
ENaC(1:300), p-AK(1:1000), Akt (1:1000), b-actin(1:500)
and Nedd4-2(1:1000) overnight at 4°C, and then reacted
with horseradish peroxidase-conjugated secondary anti-
body (1:5000)(Santa Cruz Biotechnology) at room tem-
perature for 1.5 hours. Using a Western Blot Enhanced
Chemiluminescence (ECL) method, the protein bands
were visualized by UVP Gel imaging system(Upland, CA,
USA) and analyzed by Labworks software(version 4.6).
500 μg of total proteins were immunoprecipitated from
cell lysates with the indicated antibodies at 4°C overnight
with rotation and then incubated with 40 μlo fp r o t e i n
A/G-agarose (Santa Cruz Biotechnology) beads for
4 hours at 4°C with rotation. Beads were washed four
times with lysis buffer and resuspended in sample buffer.
Samples were subjected to SDS-PAGE and transferred to
polyvinylidene fluoride membranes followed by western
blot analysis for Nedd4-2.
Statistical analysis
All data were described as mean ± S.E.M.. Statistical analy-
sis was performed by Student’s t-test and one-way analysis
of variance (ANOVA) using SPSS 12.0 software (SPSS Inc,
Chicago, USA).P value < 0.05 was considered statistically
significant.
Results
Effect of exogenous insulin on plasma insulin and glucose
levels
I n s u l i na tad o s eo f0 . 1U / k gh a dn oe f f e c to np l a s m a
glucose levels in rats (Table 1). Micro-osmotic pumps
were continuously infused throughout the experimental
period at a rate of 2.5 mU/h/rat. Human insulin levels
were maintained at a constant level in insulin-treated
rats during LPS-induced ALI (Figure 1.A). There was no
significant difference in total insulin levels between insu-
lin-treated and saline-treated rats during LPS-induced
ALI (Figure 1.B). Plasma glucose levels showed no sig-
n i f i c a n td i f f e r e n c ea t0 ,1 ,4 ,8h o u r sa f t e rL P S - i n d u c e d
ALI between insulin-treated and saline-treated rats (Fig-
ure 1.C). Also, wortmannin at a dose of 0.06 mg/kg had
no effect on plasma glucose levels in our study, which
indicated that insulin treatment did not exacerbate LPS-
induced hypoglycemia (Figure 1.C).
Effect of exogenous insulin on TNF-a, IL-6, BALF protein,
and neutrophil infiltration in LPS-induced actue lung
injury
Insulin significantly reduced LPS-induced increase in
TNF-a, IL-6, protein level, MPO activity, total cell counts,
and neutrophil counts in BALF. (p < 0.05, Figure 2. A-F).
However, the effects of insulin were significantly blocked
by wortmannin (p < 0.05, Figure 2. A-F).
Exogenous insulin attenuated lung injury in LPS-induced
actue lung injury
The lung tissue was significantly injured with the pre-
sence of intraalveolar exudate, edema, and inflammatory
cell infiltrationin LPS group compared with that in con-
trol group, as an evidence by an increase in lung injury
score(p < 0.05, Figure 3A, B, E). Insulin significantly atte-
nuated LPS-induced pathologic changes by the evidence
of a decrease in lung injury score (p < 0.05, Figure 3C, E).
Coadministration of wortmannin significantly blocked
the effect of insulin (p < 0.05, Figure 3D, E).
Table 1 Effect of exogenous insulin on plasma glucose
levels in rats
Insulin dose(0.1 U/kg)
Time after insulin(min) 0 30 60 120 240
Plasma glucose(mmol/
L)
4.7 ±
0.5
5.0 ±
0.4
4.8 ±
0.7
5.1 +
0.3
5.2 +
0.3
Data are presented as mean ± S.E.M (n = 5 per group).
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alveolar fluid clearance in LPS - induced actue lung injury
TLW was significantly decreased and AFC was signifi-
cantly increased by insulin treatment after LPS-induced
A L Ia t2 ,4 ,8h o u r s ( p < 0.05, Figure 4 A, B). Insulin-
induced decrease in TLW was significantly blocked by
wortmannin 8 hours after LPS-induced ALI (p < 0.05,
Figure 4 C). AFC was significantly increased by 40%
with insulin treatment, but was significantly decreased
by 35% with wortmannin in LPS - induced ALI (p <

Figure 1 Human insulin (A), total insulin (rat + human) (B), and plasma glucose level (C) were measured by ELISA (insulin) or
glucometer (glucose) at 0, 1, 4, 8 hours in normal and LPS-induced actue lung injury rats (n = 10 per group). Data are presented as
mean ± S.E.M.
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Figure 2 Measurement of TNF-a(A), IL-6(B), protein(C), MOP activity (D), total cell counts(E), and neutrophil counts(F) in
Bronchoalveolar lavage fluid (BALF) 8 hours after LPS-induced actue lung injury or saline treatment (n = 5 per group). Data are
presented as mean ± S.E.M.*P < 0.05 vs LPS group;# P < 0.05 vs LPS + Insulin group.
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Figure 3 Effect of exogenous insulin on the morphology of lung 8 hours after LPS-induced actue lung injury or saline treatment.( A )
Control group: No histologic changes were observed. (B) LPS group: Marked intraalveolar exudate, edema, and inflammatory cell infiltration in
the interstitial and alveolar spaces. (C) LPS + insulin group: Insulin significantly attenuated lung injury. (D) LPS + insulin + wortmannin group:
Wortmannin significantly blocked the effect of insulin in the lung pathology. (E) Lung injury score: Insulin significantly reduced ALI-induced
increase in lung injury score. Wortmannin significantly blocked the effect of insulin(n = 5 per group). Original magnification: 100 ×. Data are
presented as mean ± S.E.M.ΔP < 0.05 vs Control group;*P < 0.05 vs LPS group;# P < 0.05 vs LPS + Insulin group.
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Page 7 of 160.05, Figure 4 D). Also, amiloride, a sodium channel
inhibitor, significantly decreased insulin-induced
increase in AFC by 47% (p < 0.05, Figure 4 D).
Effect of exogenous insulin on lung localization of ENaC
in LPS-induced actue lung injury
Immunohistochemical analysis was used to determined
the lung distribution of a-, b-, and g-ENaC in rat lung 8
hours after LPS or saline treatment. Positively immunos-
tained cells appeared brown. The expressions of a-, b-,
and g-ENaC were specifically localized to the alveolar
epithelium. The number of cells expressing a-, b-, and g-
ENaC were significantly decreased in LPS-induced actue
lung injury, and were strongly increased by insulin treat-
ment, but were decreased by wortmannin (Figure 5).
Exogenous insulin increased the expression of alveolar
epithelial sodium channel in vivo and in vitro
To clarify the effect of insulin on AFC mediated by
ENaC, the expressions of a-, b-a n dg-ENaC were mea-
sured by RT-PCR and western blotting respectively. Two
forms (90 kDa and 65 kDa) of a-ENaC were detected by
western blotting (Figure 6 B; Figure 7 B). In vivo, the
mRNA and protein expression levels of a-, b-a n d
g-ENaC in rat lung showed significant increases by insu-
lin treatment 8 hours after LPS-induced ALI (P < 0.05,
Figure 6 A, B), but the mRNA and protein expression
levels of three ENaC subunits were significantly
decreased with the administration of wortmannin com-
pared with those by insulin treatment (P < 0.05, Figure 6
A, B). In vitro, the mRNA and protein expression levels
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Effect of exogenous insulin on pulmonary edema and alveolar fluid clearance in LPS-induced actue lung injury (n = 6 per
group). (A) Total lung water content at 0, 2, 4, 8 hours after LPS or insulin treatment. (B) Alveolar fluid clearance at 0, 2, 4, 8 hours after LPS or
insulin treatment. (C) Total lung water content at 8 hours after LPS-induced actue lung injury or saline treatment (D) Alveolar fluid clearance at 8
hours after LPS-induced actue lung injury or saline treatment. Albumin solution containing amiloride (5 × 10
-4 M) were injected into the alveolar
spaces. Data are presented as mean ± S.E.M.ΔP < 0.05 vs Control group;FP < 0.05 vs Amiloride group;*P < 0.05 vs LPS group;# P < 0.05 vs LPS +
Insulin group.
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insulin treatment for 2 hours in ATII cells (P < 0.05, Fig-
ure 7A, B), but pretreatment with LY294002 and Akt
inhibitor prevented the insulin-induced increase in the
mRNA and protein expression levels of a-, b-a n d
g-ENaC in ATII cells respectively (P < 0.05, Figure 7A,
B). In addtion, the mRNA and protein expression levels
of a-, b-a n dg-ENaC in ATII cells with co- administra-
tion of Akt inhibitor and SGK1inhibitor showed the simi-
lar changes compared with those by LY294002 treatment
A  
        
         Negative Control                                        Positive Control                                       LPS                     
    
LPS+Insulin                                     LPS+Insulin+Wortmannin                                          
B  
     
Negative Control                                  Positive Control                              LPS                    
Figure 5 Effect of exogenous insulin on the protein expression of a-E N a C ( A ) ,b-E N a C ( B ) ,a n dg-ENaC(C) in rat lung 8 hours after
LPS-induced actue lung injury or saline treatment. The number of positive cells was counted in randomly 5 high-power fields of each
section and averaged (five sections from 5 rats in each group). The number of cells expressing a-, b-, and g-ENaC were significantly decreased in
LPS-induced actue lung injury, compared with those in positive control group. However, the number of cells expressing a-, b-, and g-ENaC were
strongly increased by insulin treatment, but were decreased by wortmannin. Brown immunostained cell was positive (original magnification
400 ×).ΔP < 0.05 vs Positive control group;*P < 0.05 vs LPS group;# P < 0.05 vs LPS + Insulin group.
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compared with those by Akt inhibitor treatment (P <
0.05, Figure 7A, B). The bands were absent when proteins
were blotted with the a-ENaC, b-ENaC and g-ENaC
antibodies in the presence of the blocking peptide both
in vivo(Figure 6C) and in vitro(Figure 7 C). These results
indicated that insulin-induced expression of ENaC by
Akt phosphorylation via activating PI3K pathway.
C 
 
Figure 6 Expressions of alveolar epithelial sodium channel(a-ENaC, b-ENaC and g-ENaC) in rat lung were measured by RT-PCR(A) and
western blotting(B) 8 hours after LPS-induced actue lung injury or saline treatment (n = 5 per group). Proteins using the same
antibodies against a-ENaC, b-ENaC and g-ENaC plus blocking peptides specific for these antibodies were re-blotted(C). Data are presented as
mean ± S.E.M.ΔP < 0.05 vs Control group;*P < 0.05 vs LPS group;# P < 0.05 vs LPS + Insulin group.
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inhibited Nedd4-2 in vivo and in vitro
To further investigate whether regulation of ENaC by
insulin via PI3K/Akt pathway, the level of Ser
473-phos-
phorylated Akt, a reliable residue to read out of PI3K
activity [28], and Nedd4-2, a binding site for regulation
of ENaC function [29], were measured by western blot-
ting and immunoprecipitation. The protein level of
phosphorylated Akt was markedly increased in rat lung
by insulin treatment 8 hours after LPS-induced ALI(P <
0.05, Figure 8). Wortmannin abolished the insulin-
induced increase in the protein level of phosphorylated
Akt (P < 0.05, Figure 8). However, the protein level of
Nedd4-2 was significantly decreased by insulin treat-
ment and was significantly increased by co-administra-
tion of wortmannin and insulin (P <0 . 0 5 ,F i g u r e8 ) .I n
ATII cells pretreated with LY-294002 and Akt inhibitor
respectively, insulin-induced increase in the protein
levels of phosphorylated Akt were markedly decreased
(P < 0.05, Figure 9). The level of phosphorylated Akt in
ATII cells was also significantly blocked by co- adminis-
tration of Akt inhibitor and SGK1inhibitor compared
that in cells treated with insulin (P < 0.05, Figure 9). In
a contrast, the protein levels of Nedd4-2 were markedly
higher in cells pretreated with LY-294002, Akt inhibitor
and Akt inhibitor plus SGK1inhibitor compared with
those in cells treated with insulin respectively (P <0 . 0 5 ,
Figure 9). Western blot analysis of a-, b-a n dg-ENaC
immunocomplexes with anti-Nedd4-2 antibody identi-
f i e dab a n dt h a tw a st h es a m es i z ea st h eo n eo b s e r v e d
with ATII cells lysate and no such band was observed
with control IgG, which showed Nedd4-2 interacted
Figure 7 Expressions of alveolar epithelial sodium channel(a-ENaC, b-ENaC and g-ENaC) in alveolar epithelial type II cells pretreated
with LY294002(10 μM), Akt inhibitor(100 nM) and SGK1 inhibitor(10 μM) for 30 minutes before insulin treatment for 2 hours were
measured by RT-PCR(A) and western blotting(B). Proteins using the same antibodies against a-ENaC, b-ENaC and g-ENaC plus blocking
peptides specific for these antibodies were re-blotted(C). Data are presented as mean ± S.E.M.ΔP < 0.05 vs Control group;*P <# 0.05 vs Insulin
group; P < 0.05 vs Insulin + Akt inhibitor group.
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Page 11 of 16with a-, b-a n dg-ENaC in cells under basal conditions
(Figure 10A). The inhibitory effect of insulin on the
levels of Nedd4-2 immunoprecipitated in a-, b-a n dg-
ENaC were significantly abolished by LY-294002 and
Akt inhibitor repectively(Figure 10B). These findings
strongly indicated that the down-regulation of Nedd4-2
that interacted with ENaC by insulin via P13K/Akt
pathway.
Exogenous insulin decreased mortality of rats in LPS-
induced actue lung injury
Insulin treatment significantly improved the survival of
rats with ALI (P < 0.01, Figure 11), but wortmannin sig-
nificantly inhibited the survival of rats treated with insu-
lin in LPS-induced ALI (P < 0.05, Figure 11).
Discussion
In the present study, our results demonstrated insulin
played an therapic role in LPS-induced ALI and the
mechanism of ENaC-mediated AFC by which insulin
activated PI3K/Akt signaling pathway in vitro and in
vivo. Results from animal and human studies indicated
the hyperglycemia was associated with exacerbation of
inflammation and promotion of injury in ALI and insu-
lin treatment while maintaining euglycemia was found
to attenuate the inflammatory response, reduce lung
injury, and decrease the morbidity [30-34]. LPS models
the effects of Gram-negative bacteria to induced ALI in
animals and humans as a common methodology [35,36].
Therefore, a model of ALI with non-hyperglycemia and
continuously infused human insulin by micro-osmotic
Figure 8 Expressions of phosphorylated Akt and Nedd4-2 in rat lung 8 hours after LPS-induced actue lung injury or saline treatment
were measured by western blotting. The band intensity of phosphorylated Akt and Nedd4-2 were quantitated by normalized for total Akt
and b-actin respectively and expressed as fold of the control (n = 3 per group). Data are presented as mean ± S.E.M.ΔP < 0.05 vs Control group;
*P < 0.05 vs LPS group;# P < 0.05 vs LPS + Insulin group.
Figure 9 Expressions of phosphorylated Akt and Nedd4-2 in alveolar epithelial type II cells pretreated with LY294002(10 μM), Akt
inhibitor(100 nM) and SGK1 inhibitor(10 μM) for 30 minutes before insulin treatment for 2 hours were measured by western blotting.
The band intensity of phosphorylated Akt and Nedd4-2 were quantitated by normalized for total Akt and b-actin respectively and expressed as
fold of the control. Data are presented as mean ± S.E.M.ΔP < 0.05 vs Control group;*P < 0.05 vs Insulin group; # P < 0.05 vs Insulin + Akt
inhibitor group.
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levels within normal range and did not worsen LPS-
induced hypoglycemia were used in this study. Also, the
dose of human insulin infused in the study would just
only have an effect of anti-inflammatory mechanism
rather than modulation of glucose metabolism that pre-
viously reported [37]. Insulin-induced phosphorylation
of Akt in the liver was not observed by the low dose in
Figure 10 Association of Nedd4-2 with a-ENaC, b-E N a Ca n dg-ENaC. (A) Protein from alveolar epithelial type II cells lysate was
immunoprecipitated with rabbit anti- a-ENaC, b-ENaC and g-ENaC antibodies or with goat anti-rabbit IgG. Levels of coimmunoprecipitated
Nedd4-2 were detected by Western blotting (WB) with an anti-Nedd4-2 antibody. The IgG did not immunoprecipitate Nedd4-2, thus serving as a
negative control.(B) Effects of insulin, LY294002 and Akt inhibitor on Nedd4-2 in coimmunoprecipitated a-ENaC, b- ENaC and g-ENaC. Levels of
coimmunoprecipitated Nedd4-2 were significantly decreased by insulin treatment. LY294002 and Akt inhibitor significantly blocked the decrease
in coimmunoprecipitated Nedd4-2 induced by insulin. Data are normalized for the amount of Nedd4-2 immunoprecipitated and expressed as
fold of the control. Data are presented as mean ± S.E.M.ΔP < 0.05 vs Control group;*P < 0.05 vs Insulin group.
Figure 11 Effect of exogenous insulin on survival of LPS - induced actue lung injury in rats. Insulin or saline (LPS group) was
administered continuously by a micro-osmotic pump. Survival was evaluated for 72 hours. Results are presented as a Kaplan-Meier plot (n = 10
per group).*P < 0.01 vs LPS group;# P < 0.05 vs LPS + Insulin group.
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specific difference in the activation of PI3K/Akt pathway
by insulin to have an effect on inflammatory response
without affecting glucose levels. The effect of wortman-
nin did not completely block the effect of insulin
according to our results, which may be due to the possi-
bility that additional mechanisms also contribute to the
effects of insulin [38].
LPS stimulates macrophages, neutrophils, and other
immune cells to produce different mediators including
cytokines such as TNF-a, IL-6 that recruits polymorpho-
nuclear neutrophils into the injured site and contribute
to the pathogenesis of ALI and ARDS [39,40]. Activated
neutrophils release various kinds of mediators, and
secrete MPO enzyme, an indicator of neutrophil accumu-
lation in tissues by its activity [24], are recognized to be a
primary mechanism in the development of ALI [41]. In
the current study, insulin inhibited LPS-induced increase
in TNF-a, IL-6, neutrophil counts and MPO activity in
BALF. Wortmannin, a PI3K inhibitor, abolished the insu-
lin-induced reduction in TNF-a, IL-6, neutrophil counts
and MPO activity produced by LPS and insulin-induced
phosphorylation of Akt, which indicated the inhibition of
PI3K/Akt pathway. The results were consistent with pre-
vious studies that illustrated PI3K/Akt signaling pathway
played an important role as a negative regulation of LPS-
induced acute inflammatory responses in vitro and in
vivo [42-44]. In addition, activated neutrophils transmi-
grated across the endothelial surface into lung by release
of reactive oxygen species, resulting in alveolar capillary
barrier leakage, interstitial and alveolar edema after
adhering to lung endothelium [45]. In this study, insulin
attenuated LPS-induced ALI by evaluation of pulmonary
edema and protein leakage in the alveolar spaces, histolo-
gic lung injury score, and survival rate. Wortmannin
blocked the effects of insulin on LPS-induced ALI, which
showed the involvement of PI3K/Akt pathway. These
data indicated that activation of PI3K/Akt pathway by
insulin contributed to attenuation of lung injury in ALI.
Pulmonary edema accumulates as a consequence of
changes in hydrostatic pressure gradients or increased
alveolar capillary permeability. It is well accepted that
AFC, a process to remove edema fluid from the alveolar
spaces, is of particular importance by Na
+ reabsorption
from the alveolar spaces via ENaC in ALI/ARDS [8]. In
the present study, insulin enhanced AFC that resulted in
the decrease of pulmonary edema in LPS-induced ALI,
which was consistent with the finding that increase in
AFC could decrease the lung water volume [27]. Also, as
demonstrated by the present experiment, amiloride, a
sodium channel inhibitor, ininhibited AFC stimulated by
insulin, supporting the stimulatory effect of insulin on
AFC via ENaC in ALI, which was in agreement with pre-
vious study reporting that a lower AFC in a mouse model
of type 2 diabetes was mainly due to decreased active Na
+
transport by ENaC [46]. Meawhile, AFC stimulated by
insulin was significantly decreased by wortmannin indi-
cated that PI3K was essential for the maintenance of Na
+
absorption previously reported [47]. Therefore, the link
between ENaC and PI3K signaling pathway was further
investigated in our study. In vivo, the expressions of a-,
b-a n dg-ENaC and the level of phosphorylated Akt were
increased by insulin but were decreased by wortmannin
in LPS-induced ALI. LY294002, a PI3K inhibitor, mark-
edly prevented insulin-induced expressions of a-, b-a n d
g-ENaC and the level of phosphorylated Akt, which were
consistent with the results in vivo. Also, Akt inhibitor,
reported to inhibit Akt [48], blocked the expressions of
a-, b-a n dg-ENaC and the level of phosphorylated Akt
induced by insulin in ATII cells. PI3K is a central signal-
ing molecule in insulin action and the signaling transduc-
tion is mainly transmitted through its downstream target
Akt [20]. Activation of Akt allows insulin- stimulated glu-
cose uptake by inducing the translocation of type 4 glu-
cose transporter [49]. These results confirmed that
insulin-induced up-regulation of ENaC promoted AFC
via activation of PI3K/Akt pathway, but this was con-
trasts with previous finding that Akt was not involved in
the Na
+ transport by ENaC in distal renal tubule epithe-
lial cells [50]. All three subunits(a, b, g)o fE N a Cc o n t a i n
conserved PY motifs in the cytosolic COOH-terminal
domain that interacted with WW domains 3 and 4 of
Nedd4-2, which has been shown to negatively regulate
ENaC expression in vitro and in vivo [29,51,52]. The
binding of Nedd4-2 to these motifs results in internaliza-
tion and degradation of ENaC due to ubiquitination
[53-56]. The phosphorylation motif for Akt has been
proved to be identified with a conserved PY motif, which
provides a binding site for WW domains of Nedd4-2
[57-59]. In this study, we found that insulin-induced
decrease in the levels of Nedd4-2 in coimmunoprecipi-
tated a-ENaC, b-E N a Ca n dg-ENaC were blocked with
LY294002 and Akt inhibitor treatment respectively These
findings indicated the effect of insulin on inhibition of
Nedd4-2 binding to ENaC via PI3K/Akt pathway. Recent
study of Fisher rat thyroid cell proved the regulation of
a-, b-a n dg-ENaC heterologously expressed via PI3K/
Akt pathway by suppression of Nedd4-2 [60]. In addtion,
co-administration of Akt inhibitor and SGK1 inhibitor,
reported to inhibit SGK1 [61], significantly inhibited
insulin-induced increase in the expressions of a-, b-a n d
g-ENaC, as well as increased the insulin-induced decrease
in the expression of Nedd4-2 compared with administra-
tion of Akt inhibitor alone in ATII cells. These results
supported the findings that regulation of ENaC by SGK1
via inhibition of Nedd4-2 previously reported [62,63].
Here, we focused on the role of insulin-induced Akt acti-
vation on ENaC.
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Page 14 of 16In conclusion, the present data demonstrated that
insulin alleviated pulmonary edema, enchaced AFC and
attenuated lung injury in rats of LPS-induced ALI with-
out affecting blood glucose levels. Activation of Akt,
linking PI3K and insulin signaling pathway, is necessary
and sufficient for increase in the expression of ENaC by
inhibition of Nedd4-2.
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